ID   iPS-SCU-CD34+ #2
AC   CVCL_V200
SY   CB-CD34+ iPSC2
DR   Wikidata; Q54898131
RX   PubMed=20641038;
WW   https://www.isciii.es/QueHacemos/Servicios/BIOBANCOS/BNLC/Lists/Lneas%20iPS/Attachments/8/Caracteristicas%20-%20Solicitud_Deposito_iPS_SCU_CD34_2.pdf
WW   https://www.isciii.es/QueHacemos/Servicios/BIOBANCOS/BNLC/Lists/Lneas%20iPS/Attachments/8/Anexo%20-%20Anexos_iPS_SCU_CD34_2.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Andalusian Stem Cell Bank; Granada; Spain.
CC   HLA typing: A*02:01,24:02; B*51:01,51:01; C*14:02,16:02; DQB1*06:02,06:03; DRB1*13:01,15:01 (BNLC).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V199 ! iPS-SCU-CD34+ #1
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 30-01-24; Version: 10
//
RX   PubMed=20641038; DOI=10.1002/stem.471;
RA   Gutierrez-Aranda I., Ramos-Mejia V., Bueno C., Munoz-Lopez M.,
RA   Real P.J., Macia A., Sanchez L., Ligero G., Garcia-Parez J.L.,
RA   Menendez P.;
RT   "Human induced pluripotent stem cells develop teratoma more
RT   efficiently and faster than human embryonic stem cells regardless the
RT   site of injection.";
RL   Stem Cells 28:1568-1570(2010).
//